Compare BRT & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRT | EOLS |
|---|---|---|
| Founded | 1972 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.9M | 284.3M |
| IPO Year | 1994 | 2018 |
| Metric | BRT | EOLS |
|---|---|---|
| Price | $14.24 | $6.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $19.75 | $15.50 |
| AVG Volume (30 Days) | 22.9K | ★ 919.8K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | ★ 7.03% | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | ★ N/A | N/A |
| Revenue | $97,028,000.00 | ★ $297,176,000.00 |
| Revenue This Year | $3.82 | $13.27 |
| Revenue Next Year | $5.35 | $17.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.46 | ★ 11.61 |
| 52 Week Low | $13.18 | $3.86 |
| 52 Week High | $16.69 | $10.62 |
| Indicator | BRT | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 72.95 |
| Support Level | $13.18 | $6.44 |
| Resistance Level | $15.03 | $7.29 |
| Average True Range (ATR) | 0.40 | 0.36 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 19.23 | 87.80 |
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.